✦ LIBER ✦

Polymorphism of debrisoquine oxidation in New Zealand Caucasians

✍ Scribed by S. Wanwimolruk; J. R. Denton; D. G. Ferry; M. Beasley; J. R. Broughton

Publisher: Springer
Year: 1992
Tongue: English
Weight: 162 KB
Volume: 42
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00266364

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Debrisoquine oxidation polymorphism in a

Debrisoquine oxidation polymorphism in a Tasmanian population

✍ M. E. Veronese; S. McLean 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 389 KB

The debrisoquine hydroxylation phenotype was studied in 152 unselected healthy Tasmanian subjects, who were mostly Caucasians of British ancestry. Following a 10 mg oral dose of debrisoquine (D), the ratio of D/4-hydroxydebrisoquine excreted in 8-h urine (metabolic ratio, MR) was determined. MR valu

Ifosfamide plasma clearance in relation

Ifosfamide plasma clearance in relation to polymorphic debrisoquine oxidation

✍ Philip A. Philip; Lionel D. Lewis; Christopher A. James; Howard J. Rogers 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 324 KB

Ifosfamide (IF) pharmacokinetics and the plasma (NBP)-alkylating activity were determined in 33 patients with different tumours after the administration of IF as single-agent chemotherapy. All subjects had been phenotyped for debrisoquine oxidation. There is a lack of correlation between the debriso

Genetic analysis of the interethnic diff

Genetic analysis of the interethnic difference between Chinese and Caucasians in the polymorphic metabolism of debrisoquine and codeine

✍ I. Johansson; Q. Y. Yue; M.-L. Dahl; M. Heim; J. Säwe; L. Bertilsson; U. A. Meye 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 402 KB

The Far Eastern and Caucasian populations are strikingly different with respect to the debrisoquine/sparteine hydroxylation polymorphism. The number of poor metabolizers, as defined for Caucasians, is very low among Chinese and Japanese. We investigated the molecular basis for this difference by ana

Oxidative polymorphism of debrisoquine i

Oxidative polymorphism of debrisoquine is not related to human colo-rectal cancer

✍ J. M. Ladero; J. Benítez; J. F. González; E. Vargas; M. Díaz-Rubio 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 343 KB

The oxidative polymorphism of debrisoquine (DBQ) has been determined in 89 patients with colo-rectal cancer and in 556 normal control subjects. Four patients and 34 controls, with a metabolic ratio greater than 12.6, were classified as poor metabolisers of DBQ (n.s.). No difference was found in the

Polymorphic 4-hydroxylation of debrisoqu

Polymorphic 4-hydroxylation of debrisoquine in chronic discoid psoriasis

✍ P. H. Chapman; M. D. Rawlins; S. Shuster; J. R. Idle; J. C. Ritchie; R. L. Smith 📂 Article 📅 1981 🏛 Springer 🌐 English ⚖ 175 KB

Hydroxylation polymorphisms of debrisoqu

Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations

✍ G. Alván; P. Bechtel; L. Iselius; U. Gundert-Remy 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 454 KB

European data on the polymorphic metabolism of debrisoquine, sparteine, dextromethorphan and mephenytoin have been collected. No significant difference in phenotype frequencies was found between the separate series for debrisoquine, sparteine and dextromethorphan, which supports the claim that these